According to sources familiar with the matter, the White House is set to announce a drug pricing agreement with pharmaceutical giants Novartis and Roche as early as this Friday, a move that will further ease trade tensions following the U.S.-Swiss tariff stalemate. Other pharmaceutical manufacturers may also be included in this announcement, with specific details still under discussion. Previously, companies such as Pfizer and AstraZeneca have reached similar agreements with the Trump administration, agreeing to lower drug prices under certain conditions in exchange for tariff relief.
